Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
BMC Cancer|June 27, 2021
Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lungYoon Jung Jang, Dong-Gon Hyun, Chang-Min Choi, et al.Therapeutic Advances in Medical Oncology|June 29, 2026
Atezolizumab and bevacizumab plus chemotherapy versus chemotherapy in non-small cell lung cancer after tyrosine kinase inhibitor failureMoonki Hong, Junho Choi, Seoyoung Lee, et al.Journal of Cancer Research and Clinical Oncology|September 22, 2022
Central nervous systemic efficacy of immune checkpoint inhibitors and concordance between intra/extracranial response in non-small cell lung cancer patients with brain metastasisSora Kang, Hyehyun Jeong, Ji Eun Park, et al.Journal of Cancer Research and Clinical Oncology|September 6, 2022
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapyJaewon Hyung, Hyunseok Yoon, Chang-Min Choi, et al.Frontiers in Oncology|June 18, 2024
Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access programSe Hoon Park, Sang Joon Shin, Sun Young Rha, et al.Cancer Research and Treatment|December 27, 2024
Pemetrexed Maintenance versus Observation in Patients with Advanced Urothelial Carcinoma Who Completed First-line Platinum-based Chemotherapy without Disease Progression (PREMIER, KCSG GU16-05)Inkeun Park, Shinkyo Yoon, Ilhwan Kim, et al.Scientific Reports|March 17, 2024
A new model using deep learning to predict recurrence after surgical resection of lung adenocarcinomaPil-Jong Kim, Hee Sang Hwang, Gyuheon Choi, et al.Cellular Oncology (Dordrecht, Netherlands)|March 7, 2019
CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplificationJae Young Hur, Hyeong Ryul Kim, Jung Yeon Lee, et al.International Journal of Radiation Oncology, Biology, Physics|May 26, 2024
Local Ablative Therapy Combined With Pembrolizumab in Patients With Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning AnalysisHye In Lee, Eun Kyung Choi, Su Ssan Kim, et al.Translational Oncology|April 29, 2019
Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching AnalysisByung Woo Yoon, Jae Hoon Kim, Seung Hyeon Lee, et al.Pageof 9